KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Times Interest Earned (2016 - 2025)

Pacific Biosciences Of California has reported Times Interest Earned over the past 14 years, most recently at -$23.68 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$23.68 for Q4 2025, up 57.34% from a year ago — trailing twelve months through Dec 2025 was -$79.65 (down 125.21% YoY), and the annual figure for FY2025 was -$79.65, down 125.21%.
  • Times Interest Earned for Q4 2025 was -$23.68 at Pacific Biosciences Of California, down from -$22.36 in the prior quarter.
  • Over the last five years, Times Interest Earned for PACB hit a ceiling of -$10.47 in Q2 2021 and a floor of -$246.94 in Q1 2025.
  • Median Times Interest Earned over the past 5 years was -$22.76 (2024), compared with a mean of -$36.3.
  • Biggest five-year swings in Times Interest Earned: surged 84.62% in 2021 and later tumbled 985.04% in 2025.
  • Pacific Biosciences Of California's Times Interest Earned stood at -$18.59 in 2021, then decreased by 28.41% to -$23.87 in 2022, then decreased by 2.7% to -$24.52 in 2023, then plummeted by 126.4% to -$55.51 in 2024, then surged by 57.34% to -$23.68 in 2025.
  • The last three reported values for Times Interest Earned were -$23.68 (Q4 2025), -$22.36 (Q3 2025), and -$25.81 (Q2 2025) per Business Quant data.